Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
Help employers find you! Check out all the jobs and post your resume.
by Richard Daverman, PhD
April 22, 2013 -- Tasly Pharmaceutical, a company known mainly for its TCM products, paid 1.5 billion RMB ($240 million) to acquire Jiangsu TaslyDiyi Pharmaceutical, a maker of chemical drugs. TaslyDiyi was 75% owned by Tianjin Tasly Group, Tasly Pharma’s corporate parent. The remaining 25% belonged to Chongshi Ventures. In 2003, Tasly Group and Chongshi Ventures bought Diyi Pharma for 67 million RMB, which means their 10-year holding returned 22 times their initial investment. More details....
Stock Symbol: (SHA: 600535)Help employers find you! Check out all the jobs and post your resume.
